SXTP
60 Degrees Pharmaceuticals, Inc. Common Stock
NASDAQ: SXTP · HEALTHCARE · BIOTECHNOLOGY
$1.57
-1.88% today
Updated 2026-04-29
Market cap
$4.22M
P/E ratio
—
P/S ratio
2.99x
EPS (TTM)
$-11.73
Dividend yield
—
52W range
$1 – $15
Volume
1.4M
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.18M | $1.16M | $223208.00 | $253573.00 | $607574.00 | $1.01M |
| Revenue growth (YoY) | — | -46.8% | -80.8% | +13.6% | +139.6% | +65.5% |
| Cost of revenue | $702989.00 | $850742.00 | $432370.00 | $474550.00 | $384765.00 | $781695.00 |
| Gross profit | $1.48M | $309598.00 | $-209162.00 | $-220977.00 | $222809.00 | $223776.00 |
| Gross margin | 67.8% | 26.7% | -93.7% | -87.1% | 36.7% | 22.3% |
| R&D | $806683.00 | $5.51M | $525563.00 | $691770.00 | $4.99M | $2.11M |
| SG&A | $1.46M | $1.12M | $1.30M | $4.24M | $5.02M | $6.28M |
| Operating income | $-418130.00 | $-1.12M | $-1.75M | $-5.15M | $-9.71M | $-7.76M |
| Operating margin | -19.2% | -96.9% | -784.2% | -2032.8% | -1599.0% | -771.6% |
| EBITDA | $-341170.00 | $-1.01M | $-2.11M | $-1.43M | $-7.88M | $-7.28M |
| EBITDA margin | -15.6% | -87.5% | -944.9% | -562.6% | -1297.6% | -723.8% |
| EBIT | $-369035.00 | $-1.09M | $-2.19M | $-1.53M | $-7.95M | $-7.36M |
| Interest expense | $2.68M | $3.17M | $3.99M | $2.29M | $7912.00 | $7805.00 |
| Income tax | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.03M | $-4.25M | $-6.18M | $-3.77M | $-7.95M | $-7.37M |
| Net income growth (YoY) | — | -40.1% | -45.4% | +39.1% | -111.0% | +7.3% |
| Profit margin | -139.1% | -366.4% | -2769.5% | -1485.1% | -1308.0% | -732.8% |